- (1) These rules address informed consent for services provided at an RMHI, not services that may be provided for RMHI patients at another agency, either during hospitalization or after discharge.
- (2) An RMHI Treatment Review Committee (TRC) shall not authorize use of convulsive therapy, including but not limited to electroconvulsive therapy (ECT), either at the RMHI or by an outside provider. Use of convulsive therapy requires informed consent from the patient, the patient’s conservator or other legal representative, or a court order authorizing the treatment.
- (3) A Treatment Review Committee shall not authorize use of seclusion or restraint, including physical holding restraint. Use of seclusion or restraint shall be authorized only by a licensed practitioner in accordance with Chapter 0940-03-06 (Hospital Isolation and Restraint).
- (4) Nothing in these rules shall prevent the provision of treatment, including medication, or release of information in the event of an emergency situation.
Authority: T.C.A. §§ 33-1-302 through 33-1-305, 33-3-104, 33-6-107, and 33-6-1006. Administrative History: (For Administrative History prior to February, 1985 see page 1.001). New rule filed January 9, 1985; effective February 8, 1985. Administrative corrections made to agency names in December 2022 pursuant to Public Chapter 575 of 2012. Amendments filed December 22, 2025; effective March 22, 2026. PSYCHOTROPIC MEDICATIONS AT MENTAL HEALTH INSTITUTES